Raphael Pharmaceutical (RAPH) Shares Outstanding (2020 - 2025)

Raphael Pharmaceutical has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $20.2 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 7.89% year-over-year to $20.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.2 million (up 7.89% YoY) and the FY2025 annual result came in at $20.2 million, up 7.89% from the prior year.
• Shares Outstanding (Entity) improved to $20.2 million in Q4 2025 per RAPH's latest filing, from $19.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $20.2 million in Q4 2025 and troughed at $9.5 million in Q1 2021.
• A 5-year average of $16.4 million and a median of $17.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) surged 40.5% in 2022, then grew 1.07% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $13.0 million in 2021, then advanced by 20.46% to $15.6 million in 2022, then increased by 18.43% to $18.5 million in 2023, then advanced by 1.07% to $18.7 million in 2024, then advanced by 7.89% to $20.2 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $20.2 million, $19.6 million, and $19.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.